Presence of anti-rituximab antibodies predicts infusion-related reactions in patients with systemic lupus erythematosus | Annals of the Rheumatic Diseases
uni-ball Vision Elite BLX Infusion Rollerball Pens Fine Point Micro Tip, 0.5mm, Blue/Black, 12 Pack: Buy Online at Best Price in UAE - Amazon.ae
Rituximab abrogates aquaporin-4–specific germinal center activity in patients with neuromyelitis optica spectrum disorders | PNAS
Inclusion flow chart. Interval, prolonged time periods between last... | Download Scientific Diagram
Comparison of Switching from the Originator Rituximab to the Biosimilar Rituximab GP2013 or Re‑Treatment with the Originator Rituximab in Patients with Active Rheumatoid Arthritis: Safety and Immunogenicity Results from a Multicenter, Randomized,
Frontiers | Effectiveness and Safety of Rituximab in Recalcitrant Pemphigoid Diseases
Rituximab is a safe and effective long-term treatment for children with steroid and calcineurin inhibitor–dependent idiopathic nephrotic syndrome - ScienceDirect
RA | RITUXAN® (rituximab) Infusions & Dosing Schedule
Clinical courses after RTX infusion in children with refractory NS | Download Table
A, ECG prior to RTX infusion. B, Occurrence of PVC during RTX infusion.... | Download Scientific Diagram
Baseline characteristics at first RTX infusion in all MS, RRMS and PMS... | Download Table
Compassionate open-label use of rituximab following a randomised clinical trial against neuromyelitis optica (RIN-2 study): B cell monitoring-based administration - ScienceDirect
Patient characteristics At the time of RTX infusion | Download Table
Rituximab abrogates aquaporin-4–specific germinal center activity in patients with neuromyelitis optica spectrum disorders | PNAS
APPENDIX 1. | Effectiveness of Rituximab for the Treatment of Rheumatoid Arthritis in Patients with Prior Exposure to Anti-TNF: Results from the CORRONA Registry | The Journal of Rheumatology
Factors Influencing Infusion-Related Reactions Following Dosing of Reference Rituximab and PF-05280586, a Rituximab Biosimilar | SpringerLink
Effectiveness and safety of Rituximab in multiple sclerosis: an observational study from Southern Switzerland | PLOS ONE
Compassionate open-label use of rituximab following a randomised clinical trial against neuromyelitis optica (RIN-2 study): B cell monitoring-based administration - ScienceDirect
Tolerability and Safety of Switching from Rituximab to Ocrelizumab: Evaluating Factors Associated with Infusion Related Reactions - Enrique Alvarez, Kavita V. Nair, Stefan Sillau, Ian Shelton, Rebecca Seale, Sean Selva, John Corboy,
PV | RITUXAN® (rituximab) Dosing & Infusion Resources
CD20 before and after infusion of RTX. The '3rd day', '2nd week', '1st... | Download Scientific Diagram
Clinical courses after RTX infusion in children with refractory NS | Download Table
Factors Influencing Infusion-Related Reactions Following Dosing of Reference Rituximab and PF-05280586, a Rituximab Biosimilar | SpringerLink
Baseline characteristics at first RTX infusion in all MS, RRMS and PMS... | Download Table
RA | RITUXAN® (rituximab) Infusion Steps & Resources
Sustained Low Relapse Rate With Highly Variable B-Cell Repopulation Dynamics With Extended Rituximab Dosing Intervals in Multiple Sclerosis | Neurology Neuroimmunology & Neuroinflammation
